LONP1 and glioma: Since our results revealed an antitumor effect of Lon knockdown, we next investigated the efficacy of the Lon inhibitor – CC4, which is one of a series of coumarinic compounds able to selectively inhibit Lon serine protease activity [24] in glioma cells.